ANI PHARMACEUTICALS INC

ANIP · Nasdaq · SIC 2834: Pharmaceutical Preparations
271
SEC Filings

Business Summary

PART I ANI Pharmaceuticals is a diversified bio-pharmaceutical company. The Company's mission is Serving Patients, Improving Lives by developing, manufacturing, and commercializing therapeutics through its Rare Disease, Generics, and Brands businesses. On September 16, 2024, the Company acquired Alimera Sciences, Inc. ("Alimera"). In connection with the acquisition, the Company added two new products, ILUVIEN ("ILUVIEN") and YUTIQ ("YUTIQ"). See Note 3 "Business Combination" in the notes to the ...

Next Earnings

Q2 FY2026 — expected 2026-09-19

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionANIPdiscussed_in_filing Cybersecurity
topic_mentionANIPdiscussed_in_filing Trusted Computing
topic_mentionANIPdiscussed_in_filing Blockchain & Crypto
topic_mentionANIPdiscussed_in_filing Supply Chain
topic_mentionANIPdiscussed_in_filing Regulation
topic_mentionANIPdiscussed_in_filing Healthcare & Bio
topic_mentionANIPdiscussed_in_filing Sovereign & Government
topic_mentionANIPdiscussed_in_filing Cybersecurity
topic_mentionANIPdiscussed_in_filing Trusted Computing
topic_mentionANIPdiscussed_in_filing Blockchain & Crypto
topic_mentionANIPdiscussed_in_filing Supply Chain
topic_mentionANIPdiscussed_in_filing Regulation
topic_mentionANIPdiscussed_in_filing Healthcare & Bio
topic_mentionANIPdiscussed_in_filing Sovereign & Government
topic_mentionANIPdiscussed_in_filing Cybersecurity
topic_mentionANIPdiscussed_in_filing Trusted Computing
topic_mentionANIPdiscussed_in_filing Blockchain & Crypto
topic_mentionANIPdiscussed_in_filing Supply Chain
topic_mentionANIPdiscussed_in_filing Regulation
topic_mentionANIPdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-272025-12-310001023024-26-000014EDGAR98K words
2025-02-282024-12-310001023024-25-000015EDGAR
2024-02-292023-12-310001023024-24-000026EDGAR
2023-03-092022-12-310001023024-23-000005EDGAR
2022-03-152021-12-310001023024-22-000004EDGAR
2021-03-112020-12-310001023024-21-000007EDGAR
2020-02-272019-12-310001104659-20-025744EDGAR
2019-02-272018-12-310001144204-19-010541EDGAR
2018-02-272017-12-310001144204-18-011197EDGAR
2017-03-022016-12-310001144204-17-012507EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-072025-09-300001023024-25-000108EDGAR39K words
2025-08-082025-06-300001023024-25-000082EDGAR
2025-05-092025-03-310001023024-25-000046EDGAR
2024-11-082024-09-300001023024-24-000102EDGAR
2024-08-062024-06-300001023024-24-000085EDGAR
2024-05-102024-03-310001023024-24-000057EDGAR
2023-11-082023-09-300001023024-23-000043EDGAR
2023-08-092023-06-300001023024-23-000017EDGAR
2023-05-082023-03-310001023024-23-000010EDGAR
2022-11-092022-09-300001023024-22-000021EDGAR
2022-08-082022-06-300001023024-22-000017EDGAR
2022-05-102022-03-310001023024-22-000008EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-030001023024-26-000017EDGAR5K words
2026-02-270001023024-26-000013EDGAR
2026-01-120001023024-26-000005EDGAR
2025-12-010001023024-25-000113EDGAR
2025-11-100001023024-25-000110EDGAR
2025-11-070001023024-25-000107EDGAR
2025-09-260001023024-25-000099EDGAR
2025-09-080001023024-25-000089EDGAR
2025-08-080001023024-25-000081EDGAR
2025-07-290001104659-25-071769EDGAR

271 total filings indexed. 239 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001023024
TickerANIP
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: c2457c8072cd33d5b5a78b70258dd8d91acc1227d6347a74e79a1f4219c98e04
parent: 731ed024f28b611cd24cdb44e5dd79c58c53787bc133dd2b022cca2e2cb24639
content hash: a2c7d6dc1657316c06a9edeb96a3c149752be46c00b4f380c112df8fefa78bf8
signed: 2026-04-13T04:43:39.489Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf